CLINICAL RESPIRATORY JOURNAL, cilt.10, sa.6, ss.791-799, 2016 (SCI-Expanded)
Background and Aims: Lung cancer is the most common cause of malignant pleural effusions (MPEs). For patients with lung cancer and MPE, median survival is only 3-4 months. The aim of this study was to evaluate lung cancer patients with MPE by clinical and laboratory findings on admission, and determine 2-year survival rate and prognostic factors.